The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000760370p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
9/06/2026
Date registered
Help: Date registered
25/06/2026
Date last updated
Help: Date last updated
25/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
25/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
How is ejaculation affected after prostate surgery? A study using urine testing after orgasm to objectively assess ejaculatory dysfunction following transurethral resection of the prostate (TURP)
Scientific title
Post-ejaculatory urinalysis to objectively characterise ejaculatory dysfunction (retrograde ejaculation versus anejaculation) following transurethral resection of prostate (TURP) in men with benign prostatic hyperplasia: a prospective observational pilot study
Additional trial identifiers [1] 317536 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Ejaculatory dysfunction following transurethral resection of the prostate 342280 0
Benign prostatic hyperplasia 342281 0
Condition category
Condition code
Renal and Urogenital 338393 338393 0 0
Other renal and urogenital disorders
Surgery 338536 338536 0 0
Other surgery

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
This study observes ejaculatory outcomes in men undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia. Participants undergo post-ejaculatory urinalysis (PEU) at two timepoints: pre-operatively (baseline) and at six weeks post-operatively. PEU involves the participant voiding a first-stream urine sample of at least 30ml within one hour of orgasm, delivered to an accredited external pathology laboratory within 3 hours of collection. Samples are assessed for sperm count and seminal biochemical markers (if sperm and seminal biochemical markers are present, this indicates retrograde ejaculation). Ejaculatory function and quality of life are assessed using the Male Sexual Health Questionnaire-Ejaculatory Dysfunction (MSHQ-EjD) and the International Index of Erectile Function-15 (IIEF-15) at both timepoints. Each questionnaire takes no longer than 5 minutes, and both should be able to be completed within 10 minutes. The duration of observation is three months post-operatively.
Intervention code [1] 334330 0
Diagnosis / Prognosis
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345707 0
Proportion of participants with objectively confirmed retrograde ejaculation versus anejaculation at three months post-TURP
Timepoint [1] 345707 0
Three months post-operatively (primary timepoint); baseline pre-operatively
Primary outcome [2] 345708 0
Feasibility of PEU as a routine clinical assessment tool (composite outcome)
Timepoint [2] 345708 0
Assessed throughout the recruitment and follow-up period (approximately 16 months total). Recruitment rate at end of recruitment, PEU sample return rate and questionnaire completion rate at end of data collection. Drop out rate at and of data collection.
Secondary outcome [1] 462975 0
Change in patient-reported ejaculatory function
Timepoint [1] 462975 0
Baseline (pre-operative) and three months post-operatively
Secondary outcome [2] 462976 0
Change in patient-reported erectile function and sexual quality of life (composite outcome)
Timepoint [2] 462976 0
Baseline (pre-operative) and three months post-operatively
Secondary outcome [3] 462977 0
Agreement between objective PEU findings and subjective patient-reported ejaculatory status
Timepoint [3] 462977 0
Three months post-operatively
Secondary outcome [4] 462978 0
Patient and surgical factors associated with ejaculatory dysfunction (composite outcome)
Timepoint [4] 462978 0
At time of TURP

Eligibility
Key inclusion criteria
Adult males aged 18 years or older scheduled to undergo TURP for benign prostatic hyperplasia. Sexually active, defined as having ejaculated at least once in the preceding three months. Willing and able to provide informed consent. Able to collect and transport PEU samples and complete English-language study questionnaires. Available for three month post-operative follow-up. Baseline PEU confirming antegrade ejaculation with sperm count of greater than or equal to 5/HPF.
Minimum age
18 Years
Maximum age
No limit
Sex
Males
Healthy volunteers
No
Key exclusion criteria
Azoospermia or severe oligospermia (less than 5 sperm/HPF) on baseline PEU. Prior prostate surgery, concurrent prostate cancer diagnosis, previous bladder neck incision or urethral surgery. Pre-existing complete ejaculatory dysfunction or neurological conditions affecting ejaculation. History of retroperitoneal surgery or lymph node dissection. Severe erectile dysfunction (IIEF less than 8). Active urinary tract infection. Unable to comply with follow-up or provide PEU samples. Unable to complete questionnaires in English. Alpha-blocker use is permitted on the proviso the participant has no pre-existing subjective ejaculatory dysfunction.

Study design
Purpose
Duration
Longitudinal
Selection
Defined population
Timing
Prospective
Statistical methods / analysis
A formal power calculation is not feasible given the absence of prior studies using PEU in this post-TURP context. A sample of 30 participants is consistent with recommendations for pilot studies to estimate parameters and assess feasibility (Lancaster et al., J Eval Clin Pract, 2004). The primary outcome (proportion with RE versus anejaculation) will be reported as a proportion with 95% confidence intervals. Paired pre- and post-operative PEU results will be compared using McNemar's test. Agreement between objective PEU and patient-reported ejaculatory status will be assessed using Cohen's kappa. Correlations between continuous variables will be assessed using Pearson or Spearman coefficients depending on distribution. Complete-case analysis will be used; no imputation is planned. Statistical analysis will be performed using software (such as SPSS).

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 29635 0
Blacktown Hospital - Blacktown
Recruitment postcode(s) [1] 45976 0
2148 - Blacktown

Funding & Sponsors
Funding source category [1] 322097 0
Self funded/Unfunded
Name [1] 322097 0
Country [1] 322097 0
Primary sponsor type
Hospital
Name
Blacktown Hospital, Western Sydney Local Health District
Address
Country
Australia
Secondary sponsor category [1] 324989 0
Individual
Name [1] 324989 0
Henry H. Woo, Blacktown Hospital, Western Sydney Local Health District
Address [1] 324989 0
Country [1] 324989 0
Australia

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320626 0
Western Sydney Local Health District Human Research Ethics Committee
Ethics committee address [1] 320626 0
Ethics committee country [1] 320626 0
Australia
Date submitted for ethics approval [1] 320626 0
01/09/2026
Approval date [1] 320626 0
Ethics approval number [1] 320626 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151090 0
Prof Henry H. Woo
Address 151090 0
18 Blacktown Road, Blacktown Hospital, Blacktown, 2148 NSW
Country 151090 0
Australia
Phone 151090 0
+61 410608765
Fax 151090 0
Email 151090 0
Contact person for public queries
Name 151091 0
Henry H. Woo
Address 151091 0
18 Blacktown Road, Blacktown Hospital, Blacktown, 2148 NSW
Country 151091 0
Australia
Phone 151091 0
+61 98818000
Fax 151091 0
Email 151091 0
Contact person for scientific queries
Name 151092 0
Henry H. Woo
Address 151092 0
18 Blacktown Road, Blacktown Hospital, Blacktown, 2148 NSW
Country 151092 0
Australia
Phone 151092 0
+61 98818000
Fax 151092 0
Email 151092 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: This is a pilot study with a small sample size (n=30). Individual participant data will not be made publicly available to protect participant confidentiality. Aggregate results will be reported in peer-reviewed publication.



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.